Mounjaro: The first GIP & GLP-1 receptor agonist for T2D treatment
Free
Log In
Overview
To explore the first and only GIP & GLP-1 receptor agonist for T2D management
This Activity for
- Resident / Fellow
- Physician
What I will learn?
the first GIP & GLP-1 receptor agonist through an engaging discussion with investigators covering MoA, Phase III SURPASS trial program and appropriate patient.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Mounjaro: The first GIP & GLP-1 receptor agonist for T2D treatment Certificate | Certificate | Free |
VAT 15% Included